Imalux Corporation, a medical device company and developer of the Niris® Imaging System based on Optical Coherence Tomography technology, today announced the election of Michael Burke as its President and Chief Executive Officer.
Specialty
Abbott Initiates Trial of Next-Generation XIENCE PRIME™ Drug Eluting Stent
Abbott today announced the initiation of SPIRIT PRIME, a clinical trial to study the performance of the company’s next-generation XIENCE PRIME™ Everolimus Eluting Coronary Stent System.
HydroCision Introduces the “Walk in/Walk out” Option for Treatment of Herniated Discs
HydroCision Inc. announced today the launch of its new SpineJet® Percutaneous Access Set for use in herniated disc procedures using its novel cutting-with-water fluidjet technology.
Talent Stent Graft Shows Durable Performance in Patients with Abdominal Aortic Aneurysms
Through five years following initial implantation in an FDA-approved study, the Talent Abdominal Stent Graft from Medtronic, Inc., demonstrated durable safety and effectiveness in patients with abdominal aortic aneurysms.
Lumbar Matrix™ Scan From SpineMatrix® Revolutionises The Diagnosis Of Low Back Pain
A new technology that revolutionizes the way low back pain is diagnosed and treated, while also significantly reducing healthcare costs, has been introduced by SpineMatrix® Inc.
Cook Medical Announce First U.S. Placement of New Endovascular Graft Introduction System
Cook Medical has initiated enrollment in a U.S. clinical trial of its high-precision, next-generation Zenith® Low Profile AAA Endovascular Graft (Zenith AAA LP).
St. Jude Medical Announces Initial Implant of First-to-Market Connector System in the U.S.
St. Jude Medical, Inc. today announced the first implant of its Current® Plus implantable cardioverter defibrillator (ICD), featuring the SJ4 connector system.
Spinal Restoration Announces Submission of the Investigational Device Exemption (IDE) Pilot Study Results
Spinal Restoration, Inc. announced today it has submitted the 6-month primary endpoint results from an ongoing 2-year IDE pilot study of the Biostat® System to the Food and Drug Administration.
SonoSite Announces Plans to Acquire Cardiovascular Disease Management Company, CardioDynamics
SonoSite, Inc., the world leader and specialist in hand-carried and point-of-care ultrasound, today announced that it has reached an agreement to acquire CardioDynamics International Corporation.
Inspire Medical Systems Completes $17 Million Series B Financing
Inspire Medical Systems, Inc., a private medical device company, today announced it has completed a Series B financing of $17 million.
St. Jude Medical Completes Implants in U.S. Study of Deep Brain Stimulation for Parkinson’s Disease
St. Jude Medical, Inc. today announced the completion of patient implants in its U.S. pivotal clinical study of deep brain stimulation for the symptomatic treatment of Parkinson’s disease, a neurological disorder affecting approximately 6.3 million people worldwide.
EarlySense’s EverOn™ System Receives FDA Clearance and CE Mark Certification
EarlySense announced today that its EverOn contact-free patient supervision system has been cleared for marketing by the U.S. Food and Drug Administration and has received a CE Mark certification from KEMA, a Dutch notified body.
Bone Solutions Inc. receives FDA 510(K) clearance for bone void filler, OsteoCrete
Bone Solutions Inc. announced today that it has received FDA 510(k) clearance for the first device in its technology pipeline—a proprietary bone void filler, OsteoCrete™.
The Anatomical Graduated Component Total Knee Replacement
This study examined the 20-year follow-up of the cemented Anatomical Graduated Component total knee replacement carried out between 1983 and 2004.
Early Failure Of Knee Replacements
This study investigated a series of Kinemax knee replacements where the survival rate was only 75% at nine years, compared with previously recorded rates of 96% over ten years and tried to ascertain the reason for the significantly lower survival rate.
Next-Generation Mechanical Heart Pump Implanted In Heart Patients
Three patients at NewYork-Presbyterian Hospital/Columbia University Medical Center were among the first in the United States to be implanted with a next-generation artificial heart pump called the DuraHeart™ Left-Ventricular Assist System.